Upregulation of different growth factors including HER2, epidermal growth factor receptor (EGFR), and insulin-like growth factor 1 receptor (IGF1R) has been documented in BC endocrine resistance, although direct evidence has been found in support of PI3K-mediated TAM resistance (164). This evidence concerns the gene IGF1R and breast cancer.